Altered Phenotype and Enhanced Antibody-Producing Ability of Peripheral B Cells in Mice with Cd19-Driven Cre

Ying Zhao1, Sai Zhao2, Xiao-Yuan Qin2

  • 1Department of Pathophysiology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215123, China.

Cells
|February 25, 2022
PubMed

Given the importance of B lymphocytes in inflammation and immune defense against pathogens, mice transgenic for Cre under the control of Cd19 promoter (Cd19 mice) have been widely used to specifically investigate the role of loxP-flanked genes in B cell development/function. However, impacts of expression/insertion of the Cre transgene on the phenotype and function of B cells have not been carefully studied. Here, we show that the number of marginal zone B and B1a cells was selectively reduced in Cd19 mice, while B cell development in the bone marrow and total numbers of peripheral B cells were comparable between Cd19 and wild type C57BL/6 mice. Notably, humoral responses to both T cell-dependent and independent antigens were significantly increased in Cd19 mice. We speculate that these differences are mainly attributable to reduced surface CD19 levels caused by integration of the Cre-expressing cassette that inactivates one Cd19 allele. Moreover, our literature survey showed that expression of Cd19 alone may affect the development/progression of inflammatory and anti-infectious responses. Thus, our results have important implications for the design and interpretation of results on gene functions specifically targeted in B cells in the Cd19 mouse strain, for instance, in the context of (auto) inflammatory/infectious diseases.

Related Concept Videos